Hierarchical true prevalence, risk factors and clinical symptoms of tuberculosis among suspects in Bangladesh
- PMID: 35819968
- PMCID: PMC9275716
- DOI: 10.1371/journal.pone.0262978
Hierarchical true prevalence, risk factors and clinical symptoms of tuberculosis among suspects in Bangladesh
Abstract
Background: The study was aimed to estimate the true prevalence of human tuberculosis (TB); identify risk factors and clinical symptoms of TB; and detect rifampicin (RIF) sensitivity in three study areas of Bangladesh.
Methods: The cross-sectional study was conducted in three Bangladesh districts during 2018. Potential risk factors, clinical symptoms, and comorbidities were collected from 684 TB suspects. Sputum specimens were examined by LED microscopy. TB hierarchical true prevalence, risk factors and clinical symptoms were estimated and identified using a Bayesian analysis framework. Rifampicin sensitivity of M. tuberculosis (MTB) was detected by GeneXpert MTB/RIF assay.
Results: The median TB true prevalence was 14.2% (3.8; 34.5). Although overall clustering of prevalence was not found, several DOTS centers were identified with high prevalence (22.3% to 43.7%). Risk factors for TB identified (odds ratio) were age (> 25 to 45 years 2.67 (1.09; 6.99), > 45 to 60 years 3.43 (1.38; 9.19) and individuals in families/neighborhoods where a TB patient(s) has (ve) already been present (12.31 (6.79; 22.60)). Fatigue, night sweat, fever and hemoptysis were identified as important clinical symptoms. Seven of the GeneXpert MTB/RIF positive sputum specimens (65) were resistant to rifampicin.
Conclusions: About one in every seven TB suspects was affected with TB. A number of the TB patients carry multi drug resistant MTB. Hierarchical true prevalence estimation allowed identifying DOTS centers with high TB burden. Insights from this study will enable more efficient use of DOTScenters-based TB surveillance to end the TB epidemic in Bangladesh by 2035.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- WHO. Global Tuberculosis Report, 2016. http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf. (accessed 27 April 2018).
-
- WHO. Global Tuberculosis Report, 2018. https://www.who.int/publications/i/item/9789241565646 (accessed 12 June 2019).
-
- Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by in an urban community. Int J Tuberc Lung Dis. 2005; 9(9):970–6. - PubMed
-
- Park K. Park’s Textbook of Preventive and Social Medicine. 23rd ed. Jabalpur, India: M/S Banarsidas Bhanol Publishers; 2015. p97-98, p176–202.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
